Description
Tecoark-200 Injection is a high-quality formulation containing Teicoplanin 200 mg, designed to treat serious bacterial infections caused by Gram-positive organisms. This glycopeptide antibiotic is widely used in hospital settings for its strong efficacy against resistant bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus).
Formulated in a convenient 5ml vial (tray pack), Tecoark-200 ensures stability, precision dosing, and ease of administration. It works by inhibiting bacterial cell wall synthesis, ultimately leading to the elimination of infection-causing pathogens. This makes it an essential option for treating conditions such as septicemia, endocarditis, skin infections, bone infections, and respiratory tract infections.
Key Benefits:
- Effective against resistant Gram-positive bacteria
- Long half-life allows for less frequent dosing
- Suitable for severe and hospital-acquired infections
- Reliable choice for ICU and critical care use
Usage & Administration:
Tecoark-200 is administered via intravenous or intramuscular injection under medical supervision. Dosage varies depending on the severity and type of infection, as well as patient-specific factors.
Safety Information:
Patients should use this medication only under a healthcare professional’s guidance. Monitoring kidney function is recommended during prolonged therapy. Mild side effects may include injection site reactions or hypersensitivity.
Conclusion:
Tecoark-200 stands out as a trusted anti-bacterial injection for managing life-threatening infections. Its proven composition and strong antibacterial spectrum make it a dependable choice in modern clinical practice.
